Nootropic

A substance proposed to enhance cognitive function — memory, focus, creativity, or motivation — coined by Romanian chemist Corneliu Giurgea in 1972.

Why it matters

Giurgea’s original definition required five properties: enhance memory, increase resistance to disrupting agents, protect the brain from physical injury, have low toxicity, and act selectively on cognition. By that strict definition, very few compounds qualify. Modern usage has loosened the term to mean any substance taken to enhance cognition, including caffeine, L-theanine, certain prescription stimulants, and the racetam family that descended from Giurgea’s original piracetam.

In practice

For consumers the practical distinction is between evidence-supported nootropics (caffeine, L-theanine, modafinil) and the much larger market of compounds with thin clinical evidence (most racetams, many adaptogens). The “stack” framing — combining several compounds at lower individual doses — is the dominant consumer pattern.

Common confusion

“Nootropic” is sometimes treated as synonymous with “smart drug.” The category includes prescription stimulants but also covers OTC supplements with much weaker effect.

This glossary entry is editorial content reviewed against primary sources. It is not medical advice. See our Editorial Policy.